arrow
J

Justyna Janocha-Litwin

Jagiellonian University
H指数:9
被引数:264

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Are Direct-Acting Antivirals Effective and Safe for Hepatitis C Patients with Arterial Hypertension? Evidence from a Large Retrospective Real-World Study

直接抗病毒药物对合并高血压的丙型肝炎患者是否有效且安全?——来自一项大型回顾性真实世界研究的结果

2026-08-230
OA
Does rheumatoid arthritis affect the course of chronic hepatitis C and outcomes of antiviral treatment?

类风湿关节炎是否影响慢性丙型肝炎的病程及抗病毒治疗效果?

2026-05-281
PRE
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland

在战争难民涌入波兰期间,乌克兰裔患者中丙型肝炎病毒感染的治疗

2024-12-150
OAAI
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination(vol 22, 486, 2024)

抗病毒治疗后患者的随访损失作为HCV消除的额外障碍 (第22卷,486,2024)

2024-11-080
OAAI
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices

HCV感染的肝硬化和食管静脉曲张患者直接抗病毒治疗的真实世界经验

2024-08-201
OAAI
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders

在丙型肝炎病毒精神障碍患者中直接抗病毒药物的真实世界有效性和安全性

2023-07-076
OAAI
Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
2023-04-0711
OAAI
HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV)

用聚乙二醇干扰素-α2a和口服利巴韦林 (PEG-IFN-α2a/RBV) 治疗丙型肝炎期间,HTR1A,TPH2和5-HTTLPR多态性及其对抑郁症状严重程度和色氨酸分解代谢产物浓度的影响

CELLS
IF5.2
2023-03-221
OAAI
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
2022-01-135
OAAI
Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study

内皮激活和应激指数 (EASIX) 可作为血液学和非血液学新型冠状病毒肺炎患者死亡率和总生存率的早期预测指标: 多中心队列研究

2021-09-2417
OAAI
Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
2021-07-2517
OAAI